Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 630M | 3.8% |
| Gross Profit | 370M | 1.2% |
| Cost of Revenue | 260M | 7.7% |
| Operating expense | 320M | 10.4% |
| Net Income | 32M | 546.3% |
| EBITDA | 77M | 264.4% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 4.99B | 1% |
| Total Liabilities | 1.02B | 0.4% |
| Total Equity | 3.98B | 1.4% |
| Shares Outstanding | 135M | 0.1% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 54M | 3.6% |
| Cash from investing | -10M | 77.7% |
| Cash from financing | 8.7M | 107.5% |
EPS
Financial Highlights for Globus Medical in Q2 '24
Globus Medical reported a revenue of 630M, which is a 3.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 370M, marking a 1.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 260M, a 7.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 320M, showing a -10.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 32M, showing a 546.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 77M, showing a 264.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Globus Medical with growth in revenue, gross profit, and net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
